These individuals have a family history of T2D, may be negative for T1D-related autoantibodies, have marked insulin resistance and require higher insulin doses for treatment, experience higher body weight for their age with central fat distribution, and show a worse lipid profile, and higher incidence of complications on intensified insulin therapy compared to people without such a family history. The gene discussed is INS; the disease is Insulin resistance.